Abad, Catalina
Demeules, Mélanie
Guillou, Charlotte
Gondé, Henri
Zoubairi, Rachid
Tan, Yossan-Var
Pinto-Espinoza, Carolina
Schäfer, Waldemar
Mann, Anna Marei
Vouret-Craviari, Valérie
Koch-Nolte, Friedrich
Adriouch, Sahil http://orcid.org/0000-0002-0265-7773
Funding for this research was provided by:
Institut National Du Cancer (2015-137)
Deutsche Forschungsgemeinschaft (310/13)
Agence Nationale de la Recherche (ANR-18-CE92-0046-01)
Article History
Received: 26 May 2023
Accepted: 19 December 2023
First Online: 11 January 2024
Declarations
:
: The animal experimental protocols were approved by the French Ministry of Education and Research, after consultation of the ethics committee (n° APAFIS#8172).
: Not applicable.
: FKN is a co-inventor of a patent covering P2X7-antagonistic and P2X7-potentiating nanobodies.